Sterilisation of Foreign Exchange Intervention

When a central bank buys or sells foreign currency to influence its exchange rate, the transaction changes the domestic money supply. Sterilisation is the offsetting operation—usually a repo or bond sale—that removes or adds liquidity to leave the money supply unchanged. It allows the central bank to manage its currency without passively accepting the monetary consequences.

The problem: automatic monetary expansion

Imagine a central bank facing an unwanted currency appreciation—its home currency is rising against the dollar, hurting exporters. It decides to buy dollars and sell home currency to weaken its own currency. Here is what happens mechanically:

The central bank pays in home currency (say, euros) to buy dollars. This newly minted home currency enters the banking system, expanding the money supply. More money in circulation tends to lower interest rates, which makes the home currency less attractive to foreign investors (they can earn less in home-currency deposits). This partly undoes the intervention: the currency was supposed to weaken, but the lower rates are now attracting investors seeking higher yields.

This is the fundamental problem. Foreign exchange intervention, unless sterilised, automatically changes the money supply and domestic monetary policy stance. If a central bank wants to manage the currency without passively shifting its entire monetary policy framework, it must sterilise.

How sterilisation works

Sterilisation is straightforward in principle: whatever liquidity the intervention injects, a second operation removes. If the central bank buys dollars (injecting home currency), it immediately sells bonds or does a reverse repo, draining that currency back out. The money supply ends up where it started; the interest rate is unchanged; only the central bank’s asset composition has shifted (more foreign assets, fewer domestic securities).

This was textbook practice during the fixed-exchange-rate era (before 1973). Central banks routinely intervened in foreign exchange markets to keep rates aligned with gold parity. To prevent such interventions from unmooring monetary policy, they sterilised mechanically. A buy of dollars triggered an automatic bond sale; a sell of dollars triggered a bond purchase.

Modern central banks, officially indifferent to exchange rates, rarely discuss sterilisation. But it remains vital in practice, especially in emerging markets where policymakers value both exchange rate stability and monetary policy independence.

The cost of sterilisation

Sterilisation sounds costless (just move assets around), but it is expensive. The central bank buys foreign assets—say, US Treasury bills—earning perhaps 4% per year. To sterilise, it sells or borrows against home-currency securities, paying perhaps 5% or more. The central bank absorbs the spread: it earns 4% but pays 5%, a loss of 1% on the total intervention amount. Over years or decades, this accumulates.

This cost structure creates a perverse incentive. If a central bank defends a currency peg for years—buying foreign currency constantly to prevent appreciation (or selling to prevent depreciation)—the sterilisation costs mount. Eventually, either the central bank runs out of domestic bonds to sell (and cannot borrow at reasonable rates), or political pressure forces it to abandon the peg. Many emerging-market currency crises have been preceded by exhaustion of central bank sterilisation capacity.

Thailand in 1997 is the classic case. The Bank of Thailand defended the baht’s peg to the dollar through the 1990s by accumulating dollars (buying baht with dollars, pushing the baht up) while sterilising by selling domestic bonds. The sterilisation costs ate into foreign reserves; eventually, reserves were depleted and the peg snapped, triggering the Asian financial crisis.

Feasibility limits

Sterilisation is only possible if the central bank has room to manoeuvre. It needs either domestic bonds to sell, or enough credibility to borrow at reasonable rates. A wealthy, stable central bank (e.g., the Federal Reserve, the ECB) can sterilise almost indefinitely because markets trust its liabilities. A weak, emerging-market central bank with limited balance sheet depth may run out of sterilisation capacity quickly.

The size of intervention also matters. If a central bank tries to intervene massively—buying billions of dollars—it may not have enough domestic bonds to sell. Or selling so many bonds at once pushes yields up sharply, crowding out private borrowing. The intervention, meant to weaken the currency, backfires: higher yields make the currency attractive again.

Some central banks resort to non-market sterilisation: they require banks to hold higher reserve requirements, or they sell securities to the government at special rates, or they simply let the domestic money supply expand partially. This degrades the sterilisation but is sometimes politically necessary.

Unsterilised intervention

Occasionally, a central bank explicitly chooses not to sterilise. This is most common when policy is already loose and monetary expansion is desired. During the 2008 crisis, many central banks bought foreign currency without sterilising, allowing the money supply to expand in line with the intervention. The goal was both to manage the currency and to inject liquidity, so sterilisation would have been counterproductive.

Unsterilised intervention can also signal policy intent. If a central bank buys foreign currency and allows the money supply to rise, it is saying: “We are committed to currency weakness and monetary expansion together.” Markets may respond more strongly than to a sterilised intervention, which is ambiguous (is the central bank serious about the currency, or just going through the motions?).

Modern context

In today’s floating-rate world, pure sterilisation of unannounced interventions is rare; most developed central banks rarely intervene in foreign exchange markets at all. When they do (e.g., during acute financial crisis or volatility spikes), they usually announce it transparently, and the market adjustment is swift enough that formal sterilisation may not be needed.

But the principle remains essential in emerging markets and in any scenario where a central bank wants to decouple exchange rate policy from domestic monetary policy. Central banks in small, open economies—Singapore, Chile, many others—routinely sterilise their foreign exchange operations to maintain independent interest rate policy while managing their currency. The mechanics are the same: buy foreign currency, sell bonds; sell foreign currency, buy bonds.

See also